在胚胎干细胞中,BCR-ABL促进了造血干细胞和原生细胞的形成
Jérôme Artus1, Alina Zenych2, Isidora Simanic3
1INSERM UMRS-1310, Paris Saclay University, Villejuif, France; Paris Saclay University, Faculty of Medicine, Kremlin-Bicêtre, France.
Experimental hematology
|June 18, 2023
概括
研究人员开发了一种新的Tet-ON系统,以研究BCR-ABL1如何影响从多能干细胞 (PSC) 产生血造干细胞 (HSC). 这个系统有助于了解慢性骨髓性白血病 (CML) 和HSC的发展.
科学领域:
- 血液形成的研究研究.
- 干细胞生物学 干细胞生物学
- 在瘤学瘤学.
背景情况:
- 从多能干细胞 (PSC) 生成造血干细胞 (HSC) 对于理解血液发育和慢性骨髓性白血病 (CML) 等疾病至关重要.
- 之前的研究表明,胚胎干细胞 (ESC) 衍生的造血细胞中的BCR-ABL瘤基因表达可以导致长期的再生潜力.
- 了解BCR-ABL1氨酸激酶活性在造血细胞分化中的精确作用至关重要.
研究的目的:
- 为了研究血液形成分化过程中BCR-ABL1氨酸激酶活性的分子机制.
- 建立一个可控制的系统来研究从小鼠ESC (mESC) 来生成HSC.
- 使用可诱导的BCR-ABL1表达系统建模CML启动和维护.
主要方法:
- 在小鼠ESC (mESC) 中设计了一种Tet-ON可诱导系统,用于多克西环素 (dox) 调节的BCR-ABL1表达.
- 分析了表达BCR-ABL1原始体的细胞表面标记物和转录组.
- 进行长期培养启动细胞 (LTC-IC) 试验,以评估自我更新和分化潜力.
主要成果:
- 用多西环素控制的BCR-ABL1表达调节了来自mESCs的不成熟的造血祖先的形成和维持.
- 这些祖先可以在体外扩展,并表现出类似于野生类型HSC的分子特征.
- LTC-IC测定证实了自我更新能力,对红状腺和髓状腺血统的分化偏差.
结论:
- 开发的Tet-ON系统为研究ESC衍生的血液形成提供了一个独特的体外模型.
- 该模型提供了关于CML启动和维护机制的见解.
- 这些发现有助于更好地了解HSC生成和调节.
更多相关视频
10:25Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
Published on: August 9, 2019
9.4K
11:40Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
Published on: October 20, 2014
8.6K
相关概念视频
Hematopoiesis
5.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.4K
Multipotency of Hematopoietic Stem Cells
3.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.2K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Production of Formed Elements
1.5K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.5K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
